Abaxis Inc (ABAX): Richard Bastiani , director of Abaxis Inc sold 5,000 shares on Jun 8, 2016. The Insider selling transaction was reported by the company on Jun 10, 2016 to the Securities and Exchange Commission. The shares were sold at $46.73 per share for a total value of $233,735.77 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 19, 2016, Achim Henkel (Managing Director-Europe) sold 5,000 shares at $44.42 per share price.On May 11, 2016, Henk Evenhuis (director) sold 3,000 shares at $45.00 per share price.Also, On Feb 11, 2016, Vernon E Altman (director) purchased 303 shares at $39.87 per share price.On Dec 10, 2015, Craig Tockman (VP-Sales & Mktg, Animal Health) sold 560 shares at $54.44 per share price.
Abaxis Inc: On Thursday, Jun 9, 2016 heightened volatility was witnessed in Abaxis Inc which led to swings in the share price. The shares opened for trading at $46.64 and hit $47.12 on the upside , eventually ending the session at $46.89, with a gain of 0.51% or 0.24 points. The heightened volatility saw the trading volume jump to 97,914 shares. The 52-week high of the share price is $58.15 and the company has a market cap of $1,055 M . The 52-week low of the share price is at $37.71.
Company has been under the radar of several Street Analysts.Abaxis Inc is Reiterated by Canaccord Genuity to Hold while Lowering the Price Target of the company shares to $ 42 from a previous price target of $47 . The Rating was issued on Apr 1, 2016.
Abaxis Inc. is a developer manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company operates through the two segments: the medical market and the veterinary market. The Company’s medical market customer group consists of physicians’ office practices across multiple specialties urgent care outpatient and walk-in clinics health screening operations home care providers and nursing homes. The Company’s medical market products include: Piccolo chemistry analyzers and consumable products. The Company’s veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs VetScan hematology instruments and related reagent kits VetScan VSpro specialty analyzers and related consumables VetScan i-STAT analyzers and related consumables and VetScan rapid tests.